Methoserpidine
Methoserpidine is an antihypertensive drug related to reserpine.[1]
Names | |
---|---|
IUPAC name
Methyl 10,17α-dimethoxy-18β-[(3,4,5-trimethoxybenzoyl)oxy]-3β,20α-yohimban-16β-carboxylate | |
Systematic IUPAC name
Methyl (1S,2R,3R,4aS,13bR,14aS)-2,10-dimethoxy-3-[(3,4,5-trimethoxybenzoyl)oxy]-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2′,3′:3,4]pyrido[1,2-b]isoquinoline-1-carboxylate | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
ECHA InfoCard | 100.011.576 |
EC Number |
|
PubChem CID |
|
UNII | |
| |
| |
Properties | |
C33H40N2O9 | |
Molar mass | 608.688 g·mol−1 |
Pharmacology | |
C02AA06 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
References
- Jones, D. L.; Michael, A. M.; Ommer, J. P. (1961). "Clinical Trial of Methoserpidine in General Practice". British Medical Journal. 2 (5269): 1738–1741. doi:10.1136/bmj.2.5269.1738. PMC 1970934. PMID 14452236.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.